PHILADELPHIA, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for ...

Mainz Biomed (NASDAQ: MYNZ) on Tuesday said that it entered into a securities purchase agreement for a $6.0 million private placement with investor David Lazar, aimed at strengthening liquidity and ...

CAMBRIDGE, Mass., Sept. 10, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of ...

$5M private placement financing with participation from new and existing stockholders and a strategic partner with deep obesity expertise significantly strengthens Company’s financial position as the ...

Kyle Samani, Managing Partner of Multicoin Capital, to Become Chairman of the Board of Directors, Effective Upon the Closing of the Private Placement Private Placement is the Largest Solana-focused ...

Kiboko Gold Inc. (TSXV: KIB) (“Kiboko” or the “Company”) announces that, in connection with its non-brokered private placement announced on September 30, 2025 and amended on November 27, 2025 (the ...